The outlook revision reflects Moody’s Investors Service’s expectation that Lifespan will continue to improve its financial performance over the next several years.
Moody’s also affirmed the “Baa2” rating on Lifespan’s $300 million of debt and its “Baa2” issuer rating.
The rating affirmation is based on a number of factors, including Lifespan’s large size, leading market share and role as a provider of unique medical care and teaching services in the state.
More articles on healthcare finance:
This week’s 5 must-reads for hospital CFOs
CMS projects next decade of health expenditures, enrollment: 5 things to know
Kno2’s cloud fax technology coming to Aprima customers
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
